[Plasma thyroid hormones and TSH during the early stage of acute myocardial infarction (author's transl)]. 1980

W Geisthövel, and B Perschke, and R Hehrmann, and R Ködding, and A von zur Mühlen, and H Klein

In 21 males (age 50-78 yrs) without endocrine diseases, plasma thyroxine, triiodothyronine, reverse-triiodothyronine and TSH were determined by specific RIAs in the early stage of an acute myocardial infarction. Blood was taken every 4 hours up to 43 hours after admission. The patients were separated in 2 groups, depending on the severity of the infarction (group A with 11 patients = severe infarction; group B with 10 patients = not severe infarction). 25 healthy men served as an aged-matched control group (age 56-83 yrs). Thyroxine in all patients (group A and B together) did not show essential fluctuations during the 43 hours of observation. The mean values were elevated, the individual values were predominantly in the normal range. There were no significant differences between the groups A and B. As well in the total-patients group as in the groups A and B already on admission, T3 was diminished and went on falling during the 43 hours. From 35 hours after admission, T3 was significantly decreased in group A compared to group B. On admission, rT3 was elevated in both the total-patients group and group A and B; it reached its maximum after 19 hours. Group A showed from 7 hours after admission a tendency more increased levels compared to group B. In all cases (total-patients group, group A and B) TSH levels were constant within the normal range during the whole time. The results suggest that in the early stage of myocardial infarction an important alteration in the thyroxine metabolism with enhancement of the inactive reverse-triiodothyronine production occurs very quickly. Moreover, the results show that this alteration may depend on the severity of myocardial infarction. Hypothyreoidism can be excluded because of the normal or elevated thyroxine values and the normal TSH levels.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013963 Thyroid Hormones Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs. Thyroid Hormone,Hormone, Thyroid,Hormones, Thyroid
D013972 Thyrotropin A glycoprotein hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Thyrotropin stimulates THYROID GLAND by increasing the iodide transport, synthesis and release of thyroid hormones (THYROXINE and TRIIODOTHYRONINE). Thyrotropin consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the pituitary glycoprotein hormones (TSH; LUTEINIZING HORMONE and FSH), but the beta subunit is unique and confers its biological specificity. Thyroid-Stimulating Hormone,TSH (Thyroid Stimulating Hormone),Thyreotropin,Thyrotrophin,Hormone, Thyroid-Stimulating,Thyroid Stimulating Hormone
D013974 Thyroxine The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. L-Thyroxine,Levothyroxine,T4 Thyroid Hormone,3,5,3',5'-Tetraiodothyronine,Berlthyrox,Dexnon,Eferox,Eltroxin,Eltroxine,Euthyrox,Eutirox,L-3,5,3',5'-Tetraiodothyronine,L-Thyrox,L-Thyroxin Henning,L-Thyroxin beta,L-Thyroxine Roche,Levo-T,Levothroid,Levothyroid,Levothyroxin Deladande,Levothyroxin Delalande,Levothyroxine Sodium,Levoxine,Levoxyl,Lévothyrox,Novothyral,Novothyrox,O-(4-Hydroxy-3,5-diiodophenyl) 3,5-diiodo-L-tyrosine,O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine,Oroxine,Sodium Levothyroxine,Synthroid,Synthrox,Thevier,Thyrax,Thyroxin,Tiroidine,Tiroxina Leo,Unithroid,L Thyrox,L Thyroxin Henning,L Thyroxin beta,L Thyroxine,L Thyroxine Roche,Levo T,Thyroid Hormone, T4
D014284 Triiodothyronine A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3. Liothyronine,T3 Thyroid Hormone,3,3',5-Triiodothyronine,Cytomel,Liothyronine Sodium,Thyroid Hormone, T3
D014285 Triiodothyronine, Reverse A metabolite of THYROXINE, formed by the peripheral enzymatic monodeiodination of T4 at the 5 position of the inner ring of the iodothyronine nucleus. 3,3',5'-Triiodothyronine,Reverse T3 Thyroid hormone,Reverse Triiodothyronine,3,3,5 Triiodothyronine,3,3,5-Triiodothyronine

Related Publications

W Geisthövel, and B Perschke, and R Hehrmann, and R Ködding, and A von zur Mühlen, and H Klein
January 1979, Materia medica Polona. Polish journal of medicine and pharmacy,
W Geisthövel, and B Perschke, and R Hehrmann, and R Ködding, and A von zur Mühlen, and H Klein
January 1980, Przeglad lekarski,
W Geisthövel, and B Perschke, and R Hehrmann, and R Ködding, and A von zur Mühlen, and H Klein
April 1992, Bratislavske lekarske listy,
W Geisthövel, and B Perschke, and R Hehrmann, and R Ködding, and A von zur Mühlen, and H Klein
March 1979, Zeitschrift fur Kardiologie,
W Geisthövel, and B Perschke, and R Hehrmann, and R Ködding, and A von zur Mühlen, and H Klein
April 1981, Clinical endocrinology,
W Geisthövel, and B Perschke, and R Hehrmann, and R Ködding, and A von zur Mühlen, and H Klein
February 1974, Deutsche medizinische Wochenschrift (1946),
W Geisthövel, and B Perschke, and R Hehrmann, and R Ködding, and A von zur Mühlen, and H Klein
March 1975, Nihon Naibunpi Gakkai zasshi,
W Geisthövel, and B Perschke, and R Hehrmann, and R Ködding, and A von zur Mühlen, and H Klein
January 1977, Giornale italiano di cardiologia,
W Geisthövel, and B Perschke, and R Hehrmann, and R Ködding, and A von zur Mühlen, and H Klein
November 1978, Annales de cardiologie et d'angeiologie,
W Geisthövel, and B Perschke, and R Hehrmann, and R Ködding, and A von zur Mühlen, and H Klein
February 1979, Kaku igaku. The Japanese journal of nuclear medicine,
Copied contents to your clipboard!